BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 23532107)

  • 1. Pathohistological subtype predicts survival in patients with intraductal papillary mucinous neoplasm (IPMN) of the pancreas.
    Distler M; Kersting S; Niedergethmann M; Aust DE; Franz M; Rückert F; Ehehalt F; Pilarsky C; Post S; Saeger HD; Grützmann R
    Ann Surg; 2013 Aug; 258(2):324-30. PubMed ID: 23532107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraductal papillary mucinous neoplasms of the pancreas with distinct pancreatic ductal adenocarcinomas are frequently of gastric subtype.
    Ideno N; Ohtsuka T; Kono H; Fujiwara K; Oda Y; Aishima S; Ito T; Ishigami K; Tokunaga S; Ohuchida K; Takahata S; Nakamura M; Mizumoto K; Tanaka M
    Ann Surg; 2013 Jul; 258(1):141-51. PubMed ID: 23532108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative histological subtype classification of intraductal papillary mucinous neoplasms (IPMN) by pancreatic juice cytology with MUC stain.
    Hara T; Ikebe D; Odaka A; Sudo K; Nakamura K; Yamamoto H; Itami M; Hirata T; Kashimura J; Yamaguchi T
    Ann Surg; 2013 Jun; 257(6):1103-11. PubMed ID: 23364699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequency of subtypes of biliary intraductal papillary mucinous neoplasm and their MUC1, MUC2, and DPC4 expression patterns differ from pancreatic intraductal papillary mucinous neoplasm.
    Sclabas GM; Barton JG; Smyrk TC; Barrett DA; Khan S; Kendrick ML; Reid-Lombardo KM; Donohue JH; Nagorney DM; Que FG
    J Am Coll Surg; 2012 Jan; 214(1):27-32. PubMed ID: 22112419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MUC2 expression and prevalence of high-grade dysplasia and invasive carcinoma in mixed-type intraductal papillary mucinous neoplasm of the pancreas.
    Masuda A; Arisaka Y; Hara S; Matsumoto I; Takenaka M; Sakai A; Shiomi H; Matsuki N; Sugimoto M; Fujita T; Hayakumo T; Ku Y; Ogino S; Azuma T; Kutsumi H
    Pancreatology; 2013; 13(6):583-8. PubMed ID: 24280573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristic clinicopathological features of the types of intraductal papillary-mucinous neoplasms of the pancreas.
    Ishida M; Egawa S; Aoki T; Sakata N; Mikami Y; Motoi F; Abe T; Fukuyama S; Sunamura M; Unno M; Moriya T; Horii A; Furukawa T
    Pancreas; 2007 Nov; 35(4):348-52. PubMed ID: 18090241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraductal papillary mucinous neoplasm (IPMN) of the pancreas: its histopathologic difference between 2 major types.
    Ban S; Naitoh Y; Mino-Kenudson M; Sakurai T; Kuroda M; Koyama I; Lauwers GY; Shimizu M
    Am J Surg Pathol; 2006 Dec; 30(12):1561-9. PubMed ID: 17122512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncocytic-type intraductal papillary mucinous neoplasms: a unique malignant pancreatic tumor with good long-term prognosis.
    Marchegiani G; Mino-Kenudson M; Ferrone CR; Warshaw AL; Lillemoe KD; Fernández-del Castillo C
    J Am Coll Surg; 2015 May; 220(5):839-44. PubMed ID: 25840549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pancreatic juice cytology and subclassification of intraductal papillary mucinous neoplasms of the pancreas.
    Hibi Y; Fukushima N; Tsuchida A; Sofuni A; Itoi T; Moriyasu F; Mukai K; Aoki T
    Pancreas; 2007 Mar; 34(2):197-204. PubMed ID: 17312458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraductal papillary-mucinous neoplasms of the gastric and intestinal types may have less malignant potential than the pancreatobiliary type.
    Takasu N; Kimura W; Moriya T; Hirai I; Takeshita A; Kamio Y; Nomura T
    Pancreas; 2010 Jul; 39(5):604-10. PubMed ID: 20124938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of clinical meaning of histological subtypes of intraductal papillary mucinous neoplasm of the pancreas.
    Kang MJ; Lee KB; Jang JY; Han IW; Kim SW
    Pancreas; 2013 Aug; 42(6):959-66. PubMed ID: 23462330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endoscopic ultrasound-guided fine-needle aspiration cytology in the diagnosis of intraductal papillary mucinous neoplasms of the pancreas. A study of 8 cases.
    Salla C; Chatzipantelis P; Konstantinou P; Karoumpalis I; Sakellariou S; Pantazopoulou A; Manika Z
    JOP; 2007 Nov; 8(6):715-24. PubMed ID: 17993724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical implication of morphological subtypes in management of intraductal papillary mucinous neoplasm.
    Yamada S; Fujii T; Shimoyama Y; Kanda M; Nakayama G; Sugimoto H; Koike M; Nomoto S; Fujiwara M; Nakao A; Kodera Y
    Ann Surg Oncol; 2014 Jul; 21(7):2444-52. PubMed ID: 24562937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The expression of several types of mucin is related to the biological behavior of pancreatic neoplasms.
    Yonezawa S; Nakamura A; Horinouchi M; Sato E
    J Hepatobiliary Pancreat Surg; 2002; 9(3):328-41. PubMed ID: 12353144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct patterns of peritumoral histological findings in subtypes of intraductal papillary mucinous neoplasms of the pancreas.
    Saito M; Imada H; Suzuki T; Sata N; Yasuda Y; Maetani I; Fukushima N
    Ann Diagn Pathol; 2015 Oct; 19(5):347-52. PubMed ID: 26265194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical features and prognosis of intraductal papillary mucinous neoplasms of pancreas: analysis of 38 cases].
    Lou WH; Wang DS; Ji Y; Xu XF; Kuang TT; Ni XL; Wu WC; Jin DY
    Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(14):947-50. PubMed ID: 16759531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct pathways of pathogenesis of intraductal oncocytic papillary neoplasms and intraductal papillary mucinous neoplasms of the pancreas.
    Basturk O; Chung SM; Hruban RH; Adsay NV; Askan G; Iacobuzio-Donahue C; Balci S; Zee SY; Memis B; Shia J; Klimstra DS
    Virchows Arch; 2016 Nov; 469(5):523-532. PubMed ID: 27591765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucin gene expression in intraductal papillary-mucinous pancreatic tumours and related lesions.
    Terris B; Dubois S; Buisine MP; Sauvanet A; Ruszniewski P; Aubert JP; Porchet N; Couvelard A; Degott C; Fléjou JF
    J Pathol; 2002 Aug; 197(5):632-7. PubMed ID: 12210083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased K-ras mutation and expression of S100A4 and MUC2 protein in the malignant intraductal papillary mucinous tumor of the pancreas.
    Jang JY; Park YC; Song YS; Lee SE; Hwang DW; Lim CS; Lee HE; Kim WH; Kim SW
    J Hepatobiliary Pancreat Surg; 2009; 16(5):668-74. PubMed ID: 19412570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytopathologic diagnosis of oncocytic type intraductal papillary mucinous neoplasm: Criteria and clinical implications of accurate diagnosis.
    Reid MD; Stallworth CR; Lewis MM; Akkas G; Memis B; Basturk O; Adsay V
    Cancer Cytopathol; 2016 Feb; 124(2):122-34. PubMed ID: 26415076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.